Use of xenon as neuroprotectant in a neonatal subject
US9326996B2 · kind B2 · utility
0Cited by
3References
8Claims
0Family size
Inventors
Key dates
| Filing date | Feb 10, 2015 |
| Grant date | May 3, 2016 |
| Priority date | — |
| Expiry date | Feb 10, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of xenon in the preparation of a medicament for preventing and/or alleviating one or more anesthetic-induced neurological deficits in a neonatal subject.The present invention further relates to combinations of xenon and sevoflurane, and use thereof as preconditioning agents for administration prior to hypoxic-ischaemic injury.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.